Biotransformation and porphyringogenic action of hexachlorobenzene and its metabolites in a primary liver cell culture.
Hexachlorobenzene (HCB) is metabolized in a primary culture of chick embryo liver cells and causes porphyrin accumulation within 24 h after administration. The HCB-metabolites, pentachlorothiophenol (PCThP), pentachlorobenzene (PeCB) and pentachlorophenol (PCP) identified in liver cell culture are already known from long-term experiments with rats. The pattern of accumulated porphyrins is comparable with the pathological porphyrin pattern observed in oral feeding studies with warm blooded laboratory animals. Protein bound radioactivity was found in cell cultures treated with [14C] HCB. Addition of the monooxygenase-inhibitor piperonyl butoxide or ascorbic acid decreased the irreversible binding of 14C-metabolites. The results show that biotransformation of HCB fulfils an essential role in the onset of porphyria. Since none of the main HCB-metabolites could induce a pathological porphyrin pattern, a reactive intermediate capable of reacting with glutathione or thiol-groups of uroporphyrinogen decarboxylase (UROG-D) is believed to be responsible for the inhibition of UROG-D. The chick embryo liver cell system may be considered as a useful and sensitive system for studying the metabolism of xenobiotics in relation to their toxicity.
D000818:Animals; D001711:Biotransformation; D002478:Cells, Cultured; D002642:Chick Embryo; D002722:Chlorobenzenes / Q000378:metabolism*; D006581:Hexachlorobenzene / Q000378:metabolism* / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D011164:Porphyrias / Q000139:chemically induced; D011166:Porphyrins / Q000378:metabolism*; D014575:Uroporphyrinogen Decarboxylase / Q000037:antagonists & inhibitors
D002722:Chlorobenzenes; D011166:Porphyrins; D006581:Hexachlorobenzene; D014575:Uroporphyrinogen Decarboxylase